Company intelligence
Cell and Gene Therapy Catapult
Enhancing productivity and growth in the cell and gene therapy industry 🧬🩺🌍
About Cell and Gene Therapy Catapult
The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.
Verified activity
Signals from Cell and Gene Therapy Catapult
11 published signals
Presence & Recognition
Cell and Gene Therapy Catapult is attending the Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa in less than a month.
Reported by Cell and Gene Therapy Catapult
Presence & Recognition
Cell and Gene Therapy Catapult is attending Phacilitate's Advanced Therapies Europe event in Barcelona.
Reported by Cell and Gene Therapy Catapult
Research & Knowledge
Cell and Gene Therapy Catapult published a blog by Ted Mason discussing how automation streamlined AAV analytical capabilities through the integration of an automated DNA impurity detection assay.
Reported by Cell and Gene Therapy Catapult
Research & Knowledge
Cell and Gene Therapy Catapult published a case study from an ATAC apprentice Ted Mason showing a 30% faster assay completion time, 70% reduction in operator hands-on time, and assay comparability to manual methods.
Reported by Stephen Ward
Research & Knowledge
Cell and Gene Therapy Catapult published a blog post featuring a discussion with laboratory technician Ted Mason about the impact of automation on DNA impurity detection using the PicoGreen assay for AAV analytics.
Reported by Chris Harrison
Presence & Recognition
Cell and Gene Therapy Catapult is hosting its GMP manufacturing event in Stevenage during Life Sciences Week
Reported by Cell and Gene Therapy Catapult
People
Cell and Gene Therapy Catapult appointed Katie Fuller as the Quality Control Lead - Microbiology to support microbiology activities and maintain quality standards across the company.
Reported by Cell and Gene Therapy Catapult
Presence & Recognition
Cell and Gene Therapy Catapult is attending the European Society of Gene and Cell Therapy Congress in Hamburg from 27 to 30 October 2026.
Reported by Cell and Gene Therapy Catapult
Presence & Recognition
Cell and Gene Therapy Catapult is hosting its GMP manufacturing event during Life Sciences Week later this month
Reported by Stephen Ward
Presence & Recognition
Cell and Gene Therapy Catapult is participating in the Scottish Advanced Therapies Network in Edinburgh this September to explore the evolving role of Novel Approach Methodologies in advanced therapy development.
Reported by Cell and Gene Therapy Catapult
Research & Knowledge
Cell and Gene Therapy Catapult published a Regulatory Round-up featuring an August edition of the Regulatory Update detailing the launch of the Medicines and Healthcare products Regulatory Agency's pioneering AI health innovations regulatory sandbox.
Reported by Cell and Gene Therapy Catapult